Industry Research Reports
Home > Reports > Service & Software > Preimplantation Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Preimplantation Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Service & Software
Published Date: 2026-07-15
Pages: 102 Pages
Report ld: 6944008
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Preimplantation Genetic Screening was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The North American market for Preimplantation Genetic Screening was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Preimplantation Genetic Screening was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Preimplantation Genetic Screening was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Preimplantation Genetic Screening market include Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US), Beijing Genomics Institute (BGI) (China), etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Preimplantation Genetic Screening, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Preimplantation Genetic Screening market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Screening.
MARKET SEGMENTATION
By Company
- Illumina, Inc (US)
- Thermo Fisher Scientific Inc (US)
- Agilent Technologies, Inc (US)
- PerkinElmer, Inc (US)
- CooperSurgical, Inc (US)
- Beijing Genomics Institute (BGI) (China)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescent In-situ Hybridization (FISH)
- Comparative Genomic Hybridization (CGH)
- Single Nucleotide Polymorphism (SNP)
Segment by Application
- Single Gene Disorders
- X-linked Disorders
- HLA Typing
- Gender Identification
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Preimplantation Genetic Screening companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Preimplantation Genetic Screening revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Preimplantation Genetic Screening revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Preimplantation Genetic Screening Product Introduction
1.2 Global Preimplantation Genetic Screening Market Size Forecast (2021–2032)
1.3 Preimplantation Genetic Screening Market Trends & Drivers
1.3.1 Preimplantation Genetic Screening Industry Trends
1.3.2 Preimplantation Genetic Screening Market Drivers & Opportunities
1.3.3 Preimplantation Genetic Screening Market Challenges
1.3.4 Preimplantation Genetic Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preimplantation Genetic Screening Players Revenue Ranking (2025)
2.2 Global Preimplantation Genetic Screening Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Preimplantation Genetic Screening Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Preimplantation Genetic Screening
2.6 Preimplantation Genetic Screening Market Competitive Analysis
2.6.1 Preimplantation Genetic Screening Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Preimplantation Genetic Screening Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Preimplantation Genetic Screening revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Preimplantation Genetic Screening Market Classification
3.1 Introduction by Type
3.1.1 Next Generation Sequencing (NGS)
3.1.2 Polymerase Chain Reaction (PCR)
3.1.3 Fluorescent In-situ Hybridization (FISH)
3.1.4 Comparative Genomic Hybridization (CGH)
3.1.5 Single Nucleotide Polymorphism (SNP)
3.1.6 Global Preimplantation Genetic Screening Sales Value by Type
3.1.6.1 Global Preimplantation Genetic Screening Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Preimplantation Genetic Screening Sales Value, by Type (2021–2032)
3.1.6.3 Global Preimplantation Genetic Screening Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Single Gene Disorders
4.1.2 X-linked Disorders
4.1.3 HLA Typing
4.1.4 Gender Identification
4.2 Global Preimplantation Genetic Screening Sales Value by Application
4.2.1 Global Preimplantation Genetic Screening Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Preimplantation Genetic Screening Sales Value by Application (2021–2032)
4.2.3 Global Preimplantation Genetic Screening Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Preimplantation Genetic Screening Sales Value by Region
5.1.1 Global Preimplantation Genetic Screening Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Preimplantation Genetic Screening Sales Value by Region (2021–2026)
5.1.3 Global Preimplantation Genetic Screening Sales Value by Region (2027–2032)
5.1.4 Global Preimplantation Genetic Screening Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Preimplantation Genetic Screening Sales Value, 2021–2032
5.2.2 North America Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Preimplantation Genetic Screening Sales Value, 2021–2032
5.3.2 Europe Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Preimplantation Genetic Screening Sales Value, 2021–2032
5.4.2 Asia Pacific Preimplantation Genetic Screening Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Preimplantation Genetic Screening Sales Value, 2021–2032
5.5.2 South America Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Preimplantation Genetic Screening Sales Value, 2021–2032
5.6.2 Middle East & Africa Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preimplantation Genetic Screening Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Preimplantation Genetic Screening Sales Value, 2021–2032
6.3 United States
6.3.1 United States Preimplantation Genetic Screening Sales Value, 2021–2032
6.3.2 United States Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Preimplantation Genetic Screening Sales Value, 2021–2032
6.4.2 Europe Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Preimplantation Genetic Screening Sales Value, 2021–2032
6.5.2 China Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.5.3 China Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Preimplantation Genetic Screening Sales Value, 2021–2032
6.6.2 Japan Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Preimplantation Genetic Screening Sales Value, 2021–2032
6.7.2 South Korea Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Preimplantation Genetic Screening Sales Value, 2021–2032
6.8.2 Southeast Asia Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Preimplantation Genetic Screening Sales Value, 2021–2032
6.9.2 India Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
6.9.3 India Preimplantation Genetic Screening Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Illumina, Inc (US)
7.1.1 Illumina, Inc (US) Profile
7.1.2 Illumina, Inc (US) Main Business
7.1.3 Illumina, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
7.1.4 Illumina, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.1.5 Illumina, Inc (US) Recent Developments
7.2 Thermo Fisher Scientific Inc (US)
7.2.1 Thermo Fisher Scientific Inc (US) Profile
7.2.2 Thermo Fisher Scientific Inc (US) Main Business
7.2.3 Thermo Fisher Scientific Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
7.2.4 Thermo Fisher Scientific Inc (US) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.2.5 Thermo Fisher Scientific Inc (US) Recent Developments
7.3 Agilent Technologies, Inc (US)
7.3.1 Agilent Technologies, Inc (US) Profile
7.3.2 Agilent Technologies, Inc (US) Main Business
7.3.3 Agilent Technologies, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
7.3.4 Agilent Technologies, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.3.5 Agilent Technologies, Inc (US) Recent Developments
7.4 PerkinElmer, Inc (US)
7.4.1 PerkinElmer, Inc (US) Profile
7.4.2 PerkinElmer, Inc (US) Main Business
7.4.3 PerkinElmer, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
7.4.4 PerkinElmer, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.4.5 PerkinElmer, Inc (US) Recent Developments
7.5 CooperSurgical, Inc (US)
7.5.1 CooperSurgical, Inc (US) Profile
7.5.2 CooperSurgical, Inc (US) Main Business
7.5.3 CooperSurgical, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
7.5.4 CooperSurgical, Inc (US) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.5.5 CooperSurgical, Inc (US) Recent Developments
7.6 Beijing Genomics Institute (BGI) (China)
7.6.1 Beijing Genomics Institute (BGI) (China) Profile
7.6.2 Beijing Genomics Institute (BGI) (China) Main Business
7.6.3 Beijing Genomics Institute (BGI) (China) Preimplantation Genetic Screening Products, Services, and Solutions
7.6.4 Beijing Genomics Institute (BGI) (China) Preimplantation Genetic Screening Revenue (US$ Million), 2021–2026
7.6.5 Beijing Genomics Institute (BGI) (China) Recent Developments
8 Industry Chain Analysis
8.1 Preimplantation Genetic Screening Value Chain
8.2 Preimplantation Genetic Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Preimplantation Genetic Screening Sales Model
8.5.2 Sales Channels
8.5.3 Preimplantation Genetic Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Preimplantation Genetic Screening Market Trends
Table 2. Preimplantation Genetic Screening Market Drivers & Opportunities
Table 3. Preimplantation Genetic Screening Market Challenges
Table 4. Preimplantation Genetic Screening Market Restraints
Table 5. Global Preimplantation Genetic Screening Revenue by Company (US$ Million), 2021–2026
Table 6. Global Preimplantation Genetic Screening Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Preimplantation Genetic Screening Product Type
Table 9. Key Companies General Availability (GA) Timeline for Preimplantation Genetic Screening
Table 10. Global Preimplantation Genetic Screening Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Preimplantation Genetic Screening revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Preimplantation Genetic Screening Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Preimplantation Genetic Screening Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Preimplantation Genetic Screening Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Preimplantation Genetic Screening Sales Market Share in Value by Type (2021–2026)
Table 17. Global Preimplantation Genetic Screening Sales Market Share in Value by Type (2027–2032)
Table 18. Global Preimplantation Genetic Screening Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Preimplantation Genetic Screening Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Preimplantation Genetic Screening Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Preimplantation Genetic Screening Sales Market Share in Value by Application (2021–2026)
Table 22. Global Preimplantation Genetic Screening Sales Market Share in Value by Application (2027–2032)
Table 23. Global Preimplantation Genetic Screening Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Preimplantation Genetic Screening Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Preimplantation Genetic Screening Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Preimplantation Genetic Screening Sales Value by Region (%), 2021–2026
Table 27. Global Preimplantation Genetic Screening Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Preimplantation Genetic Screening Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Preimplantation Genetic Screening Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Preimplantation Genetic Screening Sales Value, (US$ Million), 2027–2032
Table 31. Illumina, Inc (US) Basic Information List
Table 32. Illumina, Inc (US) Description and Business Overview
Table 33. Illumina, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Preimplantation Genetic Screening Business of Illumina, Inc (US) (2021–2026)
Table 35. Illumina, Inc (US) Recent Developments
Table 36. Thermo Fisher Scientific Inc (US) Basic Information List
Table 37. Thermo Fisher Scientific Inc (US) Description and Business Overview
Table 38. Thermo Fisher Scientific Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Preimplantation Genetic Screening Business of Thermo Fisher Scientific Inc (US) (2021–2026)
Table 40. Thermo Fisher Scientific Inc (US) Recent Developments
Table 41. Agilent Technologies, Inc (US) Basic Information List
Table 42. Agilent Technologies, Inc (US) Description and Business Overview
Table 43. Agilent Technologies, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Preimplantation Genetic Screening Business of Agilent Technologies, Inc (US) (2021–2026)
Table 45. Agilent Technologies, Inc (US) Recent Developments
Table 46. PerkinElmer, Inc (US) Basic Information List
Table 47. PerkinElmer, Inc (US) Description and Business Overview
Table 48. PerkinElmer, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Preimplantation Genetic Screening Business of PerkinElmer, Inc (US) (2021–2026)
Table 50. PerkinElmer, Inc (US) Recent Developments
Table 51. CooperSurgical, Inc (US) Basic Information List
Table 52. CooperSurgical, Inc (US) Description and Business Overview
Table 53. CooperSurgical, Inc (US) Preimplantation Genetic Screening Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Preimplantation Genetic Screening Business of CooperSurgical, Inc (US) (2021–2026)
Table 55. CooperSurgical, Inc (US) Recent Developments
Table 56. Beijing Genomics Institute (BGI) (China) Basic Information List
Table 57. Beijing Genomics Institute (BGI) (China) Description and Business Overview
Table 58. Beijing Genomics Institute (BGI) (China) Preimplantation Genetic Screening Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Preimplantation Genetic Screening Business of Beijing Genomics Institute (BGI) (China) (2021–2026)
Table 60. Beijing Genomics Institute (BGI) (China) Recent Developments
Table 61. Revenue (US$ Million) in Preimplantation Genetic Screening Business of Company 40 (2021–2026)
Table 62. Company 40 Recent Developments
Table 63. Key Raw Materials Lists
Table 64. Key Suppliers of Raw Materials Lists
Table 65. Preimplantation Genetic Screening Downstream Customers
Table 66. Preimplantation Genetic Screening Distributors List
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Preimplantation Genetic Screening Product Picture
Figure 2. Global Preimplantation Genetic Screening Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 4. Preimplantation Genetic Screening Report Years Considered
Figure 5. Global Preimplantation Genetic Screening Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Preimplantation Genetic Screening Revenue in 2025
Figure 7. Preimplantation Genetic Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Next Generation Sequencing (NGS) Picture
Figure 9. Polymerase Chain Reaction (PCR) Picture
Figure 10. Fluorescent In-situ Hybridization (FISH) Picture
Figure 11. Comparative Genomic Hybridization (CGH) Picture
Figure 12. Single Nucleotide Polymorphism (SNP) Picture
Figure 13. Global Preimplantation Genetic Screening Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Preimplantation Genetic Screening Sales Value Market Share by Type, 2025 & 2032
Figure 15. Product Picture of Single Gene Disorders
Figure 16. Product Picture of X-linked Disorders
Figure 17. Product Picture of HLA Typing
Figure 18. Product Picture of Gender Identification
Figure 19. Global Preimplantation Genetic Screening Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Preimplantation Genetic Screening Sales Value Market Share by Application, 2025 & 2032
Figure 21. North America Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 22. North America Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
Figure 23. Europe Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 24. Europe Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
Figure 25. Asia Pacific Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 26. Asia Pacific Preimplantation Genetic Screening Sales Value by Subregion (%), 2025 vs 2032
Figure 27. South America Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 28. South America Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
Figure 29. Middle East & Africa Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 30. Middle East & Africa Preimplantation Genetic Screening Sales Value by Country (%), 2025 vs 2032
Figure 31. Key Countries/Regions Preimplantation Genetic Screening Sales Value (%), 2021–2032
Figure 32. United States Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 33. United States Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 34. United States Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 35. Europe Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 36. Europe Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 37. Europe Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 38. China Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 39. China Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 40. China Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 41. Japan Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 42. Japan Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 43. Japan Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 44. South Korea Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 45. South Korea Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 46. South Korea Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 47. Southeast Asia Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 48. Southeast Asia Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 49. Southeast Asia Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 50. India Preimplantation Genetic Screening Sales Value (US$ Million), 2021–2032
Figure 51. India Preimplantation Genetic Screening Sales Value by Type (%), 2025 vs 2032
Figure 52. India Preimplantation Genetic Screening Sales Value by Application (%), 2025 vs 2032
Figure 53. Preimplantation Genetic Screening Value Chain
Figure 54. Preimplantation Genetic Screening Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Preimplantation Genetic Screening market?
The top companies in the global Preimplantation Genetic Screening market are Illumina, Inc (US)、Thermo Fisher Scientific Inc (US)、Agilent Technologies, Inc (US).
Related Reports
Global Preimplantation Genetic Screening Market Research Report 2026
The global Preimplantation Genetic Screening market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 101
USD 2900.00
(Single User License)
Global Preimplantation Genetic Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Preimplantation Genetic Screening market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 80
USD 4250.00
(Single User License)
Preimplantation Genetic Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Preimplantation Genetic Screening was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 92
USD 3950.00
(Single User License)
Global Preimplantation Genetic Screening Market Research Report 2025
The global market for Preimplantation Genetic Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-27
Pages: 72
USD 2900.00
(Single User License)
Global Preimplantation Genetic Screening Market Insights, Forecast to 2030
Market Analysis and Insights: Global Preimplantation Genetic Screening Market
Published Date: 2024-04-15
Pages: 92
USD 4900.00
(Single User License)
Preimplantation Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Preimplantation Genetic Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 86
USD 3950.00
(Single User License)
Global Preimplantation Genetic Screening Market Research Report 2024
The global Preimplantation Genetic Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 76
USD 2900.00
(Single User License)
Global Preimplantation Genetic Screening Market Research Report 2026
The global Preimplantation Genetic Screening market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 101
USD 2900.00 (Single User License)Global Preimplantation Genetic Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Preimplantation Genetic Screening market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 80
USD 4250.00 (Single User License)Preimplantation Genetic Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Preimplantation Genetic Screening was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 92
USD 3950.00 (Single User License)Global Preimplantation Genetic Screening Market Research Report 2025
The global market for Preimplantation Genetic Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 72
USD 2900.00 (Single User License)Global Preimplantation Genetic Screening Market Insights, Forecast to 2030
Market Analysis and Insights: Global Preimplantation Genetic Screening Market
Published: 2024-04-15
Pages: 92
USD 4900.00 (Single User License)Preimplantation Genetic Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Preimplantation Genetic Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 86
USD 3950.00 (Single User License)Global Preimplantation Genetic Screening Market Research Report 2024
The global Preimplantation Genetic Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 76
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now